18 Der var ingen statistisk signifikant forskel i incidensen af MI (klinisk MI og ikke symptomgivende MI) mellem lumiracoxib og NSAID.
MI events in TARGET (12-month study) There was no statistically significant difference between lumiracoxib and NSAIDs for incidence of MI (clinical MI and silent MI).